Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$29.84−1.49 (-4.76%)
Close on Nov 17, 2026Market cap $9.21BP/E 21.3Yield –
Oscar Health total assets
Total assets on the balance sheet at the end of each period.
Oscar Health's total assets was $11.23B at Jun 30, 2026. For fiscal 2025 it was $6.33B, up 30.7% from the year before. The highest annual figure on record is $6.33B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.33B | +30.7% |
| FY2024 | Dec 31, 2024 | $4.84B | +34.4% |
| FY2023 | Dec 31, 2023 | $3.60B | -20.4% |
| FY2022 | Dec 31, 2022 | $4.53B | +36.3% |
| FY2021 | Dec 31, 2021 | $3.32B | +46.2% |
| FY2020 | Dec 31, 2020 | $2.27B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.23B | +75.9% |
| Q1 FY2026 | Mar 31, 2026 | $9.29B | +59.0% |
| Q4 FY2025 | Dec 31, 2025 | $6.33B | +30.7% |
| Q3 FY2025 | Sep 30, 2025 | $5.75B | +28.2% |
| Q2 FY2025 | Jun 30, 2025 | $6.38B | +27.5% |
| Q1 FY2025 | Mar 31, 2025 | $5.84B | +32.2% |
| Q4 FY2024 | Dec 31, 2024 | $4.84B | +34.4% |
| Q3 FY2024 | Sep 30, 2024 | $4.48B | +33.8% |
| Q2 FY2024 | Jun 30, 2024 | $5.01B | +9.7% |
| Q1 FY2024 | Mar 31, 2024 | $4.42B | -1.4% |
| Q4 FY2023 | Dec 31, 2023 | $3.60B | -20.4% |
| Q3 FY2023 | Sep 30, 2023 | $3.35B | -22.3% |
| Q2 FY2023 | Jun 30, 2023 | $4.56B | -3.9% |
| Q1 FY2023 | Mar 31, 2023 | $4.48B | +3.0% |
| Q4 FY2022 | Dec 31, 2022 | $4.53B | +36.3% |
| Q3 FY2022 | Sep 30, 2022 | $4.31B | +35.9% |
| Q2 FY2022 | Jun 30, 2022 | $4.75B | +28.2% |
| Q1 FY2022 | Mar 31, 2022 | $4.35B | +21.0% |
| Q4 FY2021 | Dec 31, 2021 | $3.32B | +46.2% |
| Q3 FY2021 | Sep 30, 2021 | $3.17B | – |
| Q2 FY2021 | Jun 30, 2021 | $3.71B | – |
| Q1 FY2021 | Mar 31, 2021 | $3.59B | – |
| Q4 FY2020 | Dec 31, 2020 | $2.27B | – |
See a number that looks wrong?